The epiblast (Epi) is the source of embryonic stem (ES) cells and all embryonic tissues. It differentiates alongside the primitive endoderm (PrE) in a randomly distributed "salt and pepper" pattern from the inner cell mass (ICM) during preimplantation of the mammalian embryo. NANOG and GATA6 are key regulators of this binary differentiation event, which is further modulated by heterogeneous FGF signalling. When and how Epi and PrE lineage specification is initiated within the developing embryo is still unclear. Here we generated NANOG and GATA6 double KO (DKO) mouse embryos and performed single-cell expression analyses. We found that the ICM was unable to differentiate in the DKO mice, allowing us to characterize the ICM precursor state. The normally heterogeneous expression of Fgf4 between cells was significantly reduced in DKO ICMs, impairing FGF signalling. In contrast, several pluripotency markers did still display cell-to-cell expression variability in DKO ICMs. This revealed a primary heterogeneity independent of NANOG, GATA6 and FGF signalling that may also be conserved in humans. We found that NANOG is key in the initiation of epiblast specification already between the 16-and 32-cell stages, enabling the cell-clustered expression of many pluripotency genes. Our data uncover previously unknown biology in the early mouse embryo with potential implications for the field of pluripotent stem cells in human and other mammals.
During preimplantation, the mammalian embryo develops into a blastocyst via two cell lineage differentiation events. First, from the 16-cell (16C) stage, inner cells segregate from outer cells and form the inner-cell mass (ICM), while the outer cells produce the extraembryonic trophectoderm (TE). A second differentiation event occurs within the ICM, with the production of the epiblast (Epi), the source of embryonic stem (ES) cells and of all embryonic tissues, and primitive endoderm (PrE) cells. At the beginning of blastocyst formation, around the 20C-32C stage, all ICM cells coexpress NANOG and GATA6.
Subsequently, between the 32C and 90C stage, these cells asynchronously differentiate into Epi, expressing solely NANOG, or PrE expressing only GATA6, in an apparently random pattern Guo et al., 2010; Ohnishi et al., 2014; Plusa et al., 2008; Saiz et al., 2016) . As single Gata6 and Nanog mutations prevent the specification of PrE and Epi respectively (Bessonnard et al., 2014; Frankenberg et al., 2011; Schrode et al., 2014) , we hypothesized that in the absence of both Nanog and Gata6, ICM cells should not be able to differentiate and should remain in a precursor state, with or without cell heterogeneity. We thus generated N -/-;G -/double KO (DKO) embryos for analysis. After validating that TE and ICM were properly segregated (Supp data Fig.1a ), we examined whether ICM cells could still differentiate in these compound mutant embryos by immunofluorescence (IF) analysis of PrE or Epi specific genes. We also performed RTqPCR on whole individual ICMs from wild type (WT), single KOs (N -/and G -/-) and DKO embryos at the 32-cell stage (32C), when some ICM cells normally start to differentiate, and at stage 90C when most of the cells have acquired either an Epi or a PrE identity ( Fig. 1a) (Bessonnard et al., 2014; Plusa et al., 2008; Saiz et al., 2016) . IF (Supp data Fig.1a ,b) and RTqPCR ( Fig. 1b ; supplemental information (SI) 1) showed that none of the eight PrE markers tested (e.g., Sox17, Pdgfra, Gata4, Foxq1...) (Artus et al., 2011; Ohnishi et al., 2014; Plusa et al., 2008) were expressed in the double mutants. Thus, PrE does not differentiate in these embryos. With the 16 Epi markers, RTqPCR revealed different expression patterns ( Fig. 1b ; SI 1): expression of some of the markers (e.g., Nanog, Bmp4, Tdgf1) was significantly down regulated or absent in DKO ICMs from either 32C or 90C stages, while others remained constant (Zfp42, Prdm14) or increased (Klf2). The absence of Nanog RNA in DKO embryos indicated that NANOG is required for its own expression in embryos, which is different than the self-repression reported in ES cells (Fidalgo et al., 2012; Navarro et al., 2012) . Altogether, our gene expression analyses revealed that DKO ICM cells cannot differentiate into Epi or PrE.
To characterize the undifferentiated state of DKO ICM cells in more detail we compared the expression patterns of various markers with those in the WT embryos at different stages. We first examined expression of the pluripotency markers SOX2 and PECAM1, as they are present at stage 16C in inner cells only, during formation of the ICM, before being progressively restricted to Epi cells within the ICM at the 90C stage (Avilion et al., 2003; Fiorenzano et al., 2016; Robson et al., 2001; White et al., 2016; Wicklow et al., 2014) . Both SOX2 and PECAM1 were expressed in DKO embryos at 32C (n=4) and 90C (n=7) stages ( Figure 1c , Supp data Fig.1d ), with SOX2 displaying the same heterogeneous nuclear levels in the characteristic salt and pepper pattern as in WT embryos. This heterogeneous pattern was completely lost in the G -/embryos, where all cells of the ICM differentiate into Epi cells.
This indicates that at this later stage, heterogeneous SOX2 expression is influenced by the universal presence of NANOG and/or loss of GATA6, whereas at the 16C stage, before the ratio is established, it must be controlled differently. Thus, SOX2 expression is controlled by different inputs that are first independent and then dependent on a high NANOG/GATA6 expression ratio. SOX21 is another early marker of pluripotency that is heterogeneously expressed at the 4C stage (Goolam et al., 2016) . At the 90C stage, we found that SOX21 levels decreased in WT ICM cells compared to earlier stages (Goolam et al., 2016) and indeed this protein in undetectable in ESCs (Moretto Zita et al., 2015) that correspond to late blastocyst Epi cells (Boroviak et al., 2014) . Interestingly, DKO ICM cells exhibited a heterogeneous pattern of SOX21 (Supp data Fig.1c ), indicating the maintenance of the early expression pattern. Altogether, our results show that in the absence of NANOG and GATA6, the ICM remains at a precursor state that still displays cell heterogeneity, illustrated by the expression patterns of SOX2 and SOX21.
We hypothesized that this ICM heterogeneity in DKO mutants may be due to FGF signalling.
Fgf4 is specifically expressed in Epi cells (Frankenberg et al., 2011; Kurimoto et al., 2006) , and is one of the earliest genes that shows binary expression among ICM cells, around the 32C stage Ohnishi et al., 2014) . Fgf4 expression is not detected in N -/embryos (Frankenberg et al., 2011) , due either to the lack of activation by NANOG, or to repression by GATA6, or both. Indeed, these two transcription factors directly bind the Fgf4 locus, respectively in undifferentiated (Chen et al., 2008; Gagliardi et al., 2013) or PrE differentiated (Wamaitha et al., 2015) ES cells. Thus, after the 32C stage, Fgf4 heterogeneous expression is maintained by a high NANOG/GATA6 ratio in Epi cells. However, it is unknown whether Fgf4 expression is solely induced by this high ratio or is initially independent from it, and could thus be driving the ICM heterogeneity seen in the DKO mutants. In WT embryos, very low levels of Fgf4 transcripts were detected at 8C and 16C, while increased expression was observed in 32C and 90C ICMs (SI 1). In G -/mutants, Fgf4 expression was further induced, while it decreased in N -/embryos (SI 1). This is similar to ES cells where Nanog is required for producing high levels of Fgf4 transcripts . In contrast to the single KOs, the level of Fgf4 expression in the DKO mutants was similar to WT's at the 32C and 90C stages ( Fig.1d ). This implies that Nanog is not required for Fgf4 expression in early ICM cells. Moreover, Fgfr1 and Fgfr2 RNAs were also present in the double mutants, enabling FGF pathway signalling ( Fig. 1d ). However, in contrast to the WT, expression of FGF signalling target genes such as Dusp4, Etv4 and Spry4 (Kang et al., 2017; Morgani et al., 2018) were down-regulated in DKO mutants at the 90C stage ( Fig. 1d , Supp data Fig.1e , SI 1). Thus, when analysing the entire DKO ICM cell population, FGF signalling is not activated, despite Fgf4 and Fgfrs expression levels similar to those seen in the WT ICM, where FGF signalling is activated. Accordingly, ERK phophorylation that has been described in some precursor and PrE cells (Azami et al, Development, in press) of WT embryos was also absent in DKO ICMs (Fig. 1e , n= 5). A possible explanation for this is that, in contrast to WT embryos that display heterogeneous Fgf4 expression across ICM cells Ohnishi et al., 2014) , DKO ICM cells may all express similar levels of Fgf4, which would then be comparatively lower than in the WT cells. In WT ICMs, the differential expression would locally create high levels that reach the threshold required for inducing FGF signalling. In contrast, a globally similar but homogeneous level of FGF4 throughout the ICM may be locally lower in DKO embryos, and possibly insufficient for downstream pathway activation. To address this further, we carried out single cell gene expression analyses.
Before analysing mutant cells, we performed a quantitative analysis of gene expression in single cells of WT embryos as a reference (WT-Ref) at different time points of development (16C, 32C, 64C and 90C stages) by single-cell RNA analyses ( Fig. 2a,b ). We focused our study on known markers for PrE and Epi Fiorenzano et al., 2016; Guo et al., 2010; Kurimoto et al., 2006; Ohnishi et al., 2014; Plusa et al., 2008) genes, reported to be expressed before the 32C stage and/or linked to pluripotency in embryos or ES cells (e.g., Zscan4, Tcfcp2l1, Sox21, Prdm14) (Burton et al., 2013; Falco et al., 2007; Goolam et al., 2016; Pelton et al., 2002) , and FGF pathway genes (Kang et al., 2017; Ohnishi et al., 2014) .
Unsupervised hierarchical clustering showed that the cells regrouped according to their stage and level of differentiation (Supp data Fig. 2a ). The progressive evolution of differentiation toward Epi and PrE states was also captured by principal component analysis (PCA) ( Fig. 2c ).
Developmental time segregated cells along PC1, whereas PC2 highlighted differentiation between Epi and PrE states, which can be depicted by the levels of Fgf4 expression ( Fig. 2d ), and by several Epi and PrE markers (Supp data Fig. 2b,2c ). We then assessed the dynamics of expression for each gene at each stage (Supp data Fig. 2c , SI 2). Except for Gata6 and Fgfr2, the analysed PrE markers initiated their expression rather late between the 64C and 90C stage, consistent with their induction by a low NANOG/GATA6 ratio (Bessonnard et al., 2014; Ohnishi et al., 2014; Saiz et al., 2016) . Several Epi/pluripotency markers such as Fgf4, Prdm14, Klf2, Klf4, Tdgf1 displayed heterogeneous expression among ICM cells at the 32C stage (SI 2). As previously published Ohnishi et al., 2014) , our results showed that Fgf4 expression was low at the 16C and increased from the 32C stage in a subset of cells (SI 2), segregating the samples into two populations of Fgf4-expressing (Fgf4+ve/Epi) and non-expressing (Fgf4-ve/PrE) cells ( Fig. 2e ). Consequently, for each stage we subdivided the cells into Fgf4+ve and Fgf4-ve expression subgroups ( Fig. 2f ; SI 3). This enabled us to visualise differences between Epi and PrE cells at the 64C and 90C stage, in agreement with previous reports Kang et al., 2017; Ohnishi et al., 2014) . At the 32C stage, Prdm14, Klf2, Klf4, Tdgf1, Sox21, Sox2 and Nanog already displayed differential expression between Fgf4+ve and Fgf4-ve cells, whereas other Epi markers like Bmp4, Zfp42, Enox1 or Esrrb exhibited a later restriction to the Epi lineage ( Fig. 2f and SI 3).
We also examined the expression of some components of the FGF pathway (SI 3). As previously described (Kang et al., 2017; Molotkov et al., 2017; Ohnishi et al., 2014) Fgfr1 was expressed at similar levels between Epi (Fgf4+ve) and PrE (Fgf4-ve) cells, while Fgfr2 expression became restricted to PrE cells rather late, around the 90C stage. This confirms that all ICM cells of the early blastocyst (∼32C) are equally able to receive the FGF signal through FGFR1 (Kang et al., 2017; Molotkov et al., 2017) and that the beginning of ICM cell differentiation most likely relies only on the local FGF4 concentration.
Strikingly, Fgf4+ve cells were already significantly clustered at stage 32C on the PCA map ( Fig. 2d, 2g, 2h ). This indicated that Fgf4 expression is not stochastic at this stage and that expression of many other genes participate to segregate Fgf4 expressing cells on the map.
Indeed, several Epi/pluripotency genes displayed a similar distribution (Supp data Fig. 2c, 3b ) and the Fgf4+ve cells on the PCA map were mainly included within Nanog-, Prdm14-, Klf2-, Klf4-or Tdgf1-expressing populations (Supp data Fig. 3a, 3d ). Accordingly, significant correlations of expression were found between Fgf4 and 8 Epi/pluripotency genes at 32C (Supp data Fig. 3c ). Thus, Fgf4 expression is possibly induced by the combined activity of some of these factors, or by other unknown factor(s), restricting the expression of these genes to a subset of cells. Altogether, these results show that already at the 32C stage, a group of cells share a gene expression signature comprising several Epi/pluripotency markers together with Fgf4. This strongly suggests that the Epi state emerges earlier than previously thought, between the 16C and 32C stages.
We then carried out single-cell RNA analysis on single and double mutant embryos at stage 32C (SI 4), as our data in the WT indicated that this is the onset of Fgf4+ve cells and of Epi/PrE differentiation. PCA showed that the cells from WT and DKO genotypes aligned similarly along the PC1 axis ( Fig. 3a ; see also Supp data Fig. 4 for PCA analyses on the 4 genotypes) indicating that the DKO cells develop at the same pace. Similar to the ICM analysis (SI 1), there were many genes expressed at lower levels in DKO embryos whereas others maintained their expression (SI 4). As in WT, a subset of cells expressed Fgf4 in the DKO embryos. However, the range of Fgf4 expression levels in Fgf4+ve cells was strongly reduced (Fig. 3b ). At stage 32C in the WT cells, Gata6 was similarly expressed in Fgf4+ve
and Fgf4-ve cells (SI 3), suggesting that it probably does not have a differential impact at this stage. Thus, NANOG is required for the high expression of Fgf4 in individual cells and efficient activation of the pathway, as illustrated by the lack of pERK labelling in DKO ICMs (Fig. 1e ). The existence of a threshold level for FGF4 activation is supported by data showing that incremental doses of recombinant-FGF4 are required to differentiate PrE cells in Fgf4 mutants (Kang et al., 2013; Krawchuk et al., 2013) . Together, our results indicate that NANOG is necessary to boost Fgf4 expression in a subpopulation of cells to reach levels required for FGF pathway activation in the neighbouring cells. Thus, the FGF pathway seems to act only downstream of Epi specification.
In contrast to the WT cells, Fgf4+ve cells were not clustered in the PCA of DKO cells ( Fig.   3c , d) and Fgf4 expression did not correlate with other genes (Spearman test, p >0.05). As a whole, the PCA with DKO cells demonstrates that NANOG is required for coordinating the expression of these pluripotency genes to enable the emergence of the Epi state.
Altogether, our results show that correct Fgf4 expression at the 32C stage requires the presence of NANOG. Yet, at this stage, Nanog expression is not strictly restricted to Fgf4+ve cells. In addition, Nanog is already expressed at the 16C stage with variability between cells (Supp data Fig. 5 ). Indeed, the NANOG protein can be detected from the 8C stage (Plusa et al., 2008) and is heterogeneously distributed among nuclei around the 16C stage (Dietrich and Hiiragi, 2007) . Thus, NANOG alone does not seem to be sufficient to induce Fgf4 expression, implying that it requires a partner(s). Several genes such as Zfp42, Tdgf1, Sox21, Pecam1, had a correlated expression with Fgf4 at the 32C stage (Supp data Fig. 3c ), and maintained their RNA levels in DKO ICMs (SI 4). These pluripotency markers showed high heterogeneity in expression levels at 16C (Supp data Fig. 5 ), however their expression no longer correlated with Fgf4 at the 16C stage (Spearman test, p > 0,05). Thus, if one or several of these genes products are cooperating with NANOG to induce Epi specification, this would be likely through a stochastic activation between the 16C and 32C stages.
Single-cell RNA sequencing analyses have reported in depth cell-to-cell gene expression variation during preimplantation (Boroviak et al., 2015; Deng et al., 2014; Goolam et al., 2016; Mohammed et al., 2017; Posfai et al., 2017; Tang et al., 2011) . To further explore possible mechanisms of Epi induction we mined single-cell RNA-seq data, using ICM annotated cells from 32C stage embryos (Posfai et al., 2017) . Genes whose expression was correlated with Fgf4's at the 32C stage (SI 5) were selected from the whole transcriptome (≈ 15K genes), resulting in 888 correlated genes and 546 with an inverse correlation (Spearman test, p<0.05). Gene-to-gene expression correlations across the cells were then analysed to identify regulation networks (Fig. 4a, SI 6) . The 1434 Fgf4-correlating genes were hierarchically clustered into different subgroups, highlighted by Nanog, Etv5, Utf1, Bmp4, Klf2 and Tdgf1, revealing potential co-regulatory mechanisms. Several of these genes were already identified as Epi markers at stage 32C with the Biomark Fluidigm experiments (SI 3), supporting our data. Notably, cells expressing high levels of Utf1, Klf2 and Tdgf1, each representing different subgroups, not only co-expressed Fgf4 (Fig 4b) but also expressed high levels of Nanog transcripts (Fig 4c) . A cluster comprising Fgfr2, Dab2 and Lrpap1, which are known PrE markers (Gerbe et al., 2008; Guo et al., 2010; Kurimoto et al., 2006; Ohnishi et al., 2014) , showed a negative correlation with Fgf4 (Fig. 4 a,b ). Altogether, these RNAseq data confirmed that already at the 32C stage, a subpopulation of cells has started to acquire an Epi identity. These cells share a gene expression signature determining the earliest Epi state.
These results also revealed candidate regulatory factors for NANOG-mediated induction of the Epi state. In order to identify potential genes that could be involved in the emergence of the Epi lineage from an earlier stage, we carried out an expression correlation analysis on cells at the 16C stage (Supp data Fig. 6b , SI 5, SI 7), when the first ICM cells are produced, using the same dataset (Posfai et al., 2017) . At this stage, Fgf4 transcripts are detected in fewer cells and at lower levels compared to the 32C stage (Supp data Fig. 7a, 7b ). Only 68 genes presented a correlated expression with Fgf4 at both the 16C and 32C stage (SI 5), and the clusters identified at 32C stage were not conserved (Supp data Fig.6b ). From the 68 genes, solely Pou2f3 and Etv5 code for transcription factors (GO:000368), however their expression at the 16C stage was low compared to the 32C stage (Supp data Fig. 7a, b) . Moreover, we could not detect the ETV5 protein before the 32C stage by immunofluorescence (Supp data Fig.8 ), questioning the functional significance of the low RNA levels at the 16C stage and indicating that this protein is most likely not involved in early ICM cell heterogeneity.
Altogether, our single cell RNA analyses revealed several candidate transcription factors for inducing Fgf4 transcription together with NANOG at 32C, but are either not expressed or randomly expressed at 16C stage.
While our data revealed that levels of Fgf4 transcripts in individual cells of DKO embryos are significantly low, we cannot rule out that their presence still creates some heterogeneity among ICM cells. To exclude this, we cultured litters with DKO embryos in the presence of FGFR and MEK inhibitors from the 8C to the 90C stage as previously described (Nichols et al., 2009; Yamanaka et al., 2010) . Strikingly, SOX2 (Fig. 4d ) as well as SOX21 (Supp data Fig. 9 ) were still expressed in a mosaic pattern in DKO-inhibited ICM cells. This demonstrates that the ICM remains heterogeneous in the absence of Nanog, Gata6 and the FGF/MEK pathway. Thus, a primary ICM heterogeneity exists before NANOG, GATA6 and the FGF pathway become effective.
Collectively, our results indicate that the emergence of the Epi lineage (Fgf4+ve cells) is achieved through the coincidental expression of Nanog and other differentially expressed gene(s) in few cells between the 16C and 32C stage. The poor transcription factor expression correlations at stage 16C suggest that these coexpressions appear stochastically. However, NANOG expression variability within ICM cells (Dietrich and Hiiragi, 2007) on its own could be the source of heterogeneity. In that case, NANOG could interact with a homogeneously expressed factor produced from the 16C stage. What initiates NANOG and other factors expression heterogeneity, whether it is due to transcriptional noise or/and to other sources of variability such as cell cycle or post-translational modifications as is proposed for ES cells(Torres-Padilla and Chambers, 2014) is currently unknown in the embryo . Genes other than transcription factors, such as the ones whose expression correlated with Fgf4's at the 16C stage could be involved in cell heterogeneity and modulation of NANOG expression or activity. In addition, cell heterogeneity has been found at earlier stages, as expression of proteins including SOX21, CARM1 or PRDM14 (Burton et al., 2013; Goolam et al., 2016; Torres-Padilla et al., 2007) , and the duration of SOX2 DNA binding (White et al., 2016) are different between blastomeres at the 4C stage and can prefigure inner and outer cells. Sox2, Sox21, Prdm14 or Carm1 are not differentially expressed between blastomeres at the 8C stage (Goolam et al., 2016) and their expression is not correlated with Fgf4's at the 16C stage (SI 5). Therefore, if these genes are involved in Fgf4 expression heterogeneity, there must be a relay mechanism between the 4C and 32C stages, presumably at the posttranscriptional level. Sox21 and Prdm14 mutant mice are viable (Kiso et al., 2009, 21; Yamaji et al., 2008) and the number of NANOG-expressing cells is unchanged in Sox2 maternal-zygotic mutant embryos at 90C (Wicklow et al., 2014) , indicating that these genes are probably not required to induce the initial Epi cells.
Interestingly, Carm1 maternal-zygotic mutant blastocysts have a smaller total number of cells and a smaller number of NANOG-expressing cells (Hupalowska et al., 2018) . It would thus be interesting to examine how Fgf4 expression is induced and how Epi and PrE cells are specified in these embryos.
Thus, it remains unclear whether the emergence of Epi cells results from the stochastic coexpression of different factors or from the inheritance of an earlier cell heterogeneity.
Nevertheless, the asynchrony of Epi, and thus PrE, cell specification that is taking place between 32C and 90C stages 2,3,38 can be explained by the variability of gene expression that drives the coincidental expression of NANOG with other transcription factor(s).
We also show that ICM cell heterogeneity is present in the absence of NANOG, GATA6 and the FGF pathway, and that effective FGF signalling is a consequence of Epi specification through NANOG expression. Thus Epi specification is not induced by the absence of FGF signalling, although it is a necessary condition for its occurrence, but by other factors driving early ICM heterogeneity. Thus, a primary cell heterogeneity is present independently of the FGF pathway, and is then emphasized by NANOG, GATA6 and FGF activities to translate this early cell heterogeneity into cell differentiation. Human and other mammalian embryos are less sensitive than rodents to the FGF pathway 47-49 for establishing the "salt and pepper" expression of GATA6 and NANOG expression. Thus, this mechanism of primary ICM heterogeneity that we propose for the emergence of the Epi cells induced by NANOG and coincidental expression of currently unknown partner(s) independently of the FGF pathway, could be conserved amongst mammals.
Methods

Embryos collection and staging
Experiments were performed in accordance with French and EU guidelines for the care and use of laboratory animals. Animals were housed in a pathogen-free facility under a 12-hour light cycle. All embryos used in this study were produced from natural mattings.
Embryos were collected at 8-cell stage (8C), 16C, 32C, 64C and 90C (corresponding to 2.5, 3.0, 3.25, 3.5, and 3.75 days of embryonic development respectively). For the single cell analysis on WT embryos (WT-Ref) from the CD1 strain (Charles River or Janvier), embryos were also staged using littermates total cell counts.
Genotyping
Single and double mutant embryos were obtained from heterozygous intercrosses between G -/+ (Gata6 tm2.1Sad ) (Bessonnard et al., 2014; Sodhi et al., 2006) and N -/+ (Nanog tm1Yam ) (Mitsui et al., 2003) lines (backcrossed to CD1 mice for more than 10 generations). In a subset of embryo cultures, Gata6 tm2.1Sad allele with the Zp3-Cre transgene (de Vries et al., 2000) were used to increase the number of double mutants. Mendelian ratios were obtained for the different genotypes.
Mice and embryos were genotyped as previously described (Bessonnard et al., 2014; Frankenberg et al., 2011) . Primer pairs for Gata6 genotyping (Sodhi et al., 2006) , using the Goldstar Taq polymerase (Eurogentec) were: 5'-AGTCTCCCTGTCATTCTTCCTGCTC-3' associated to 5'-TGATCAAACCTGGGTCTACACTCCTA-3' for the mutated allele and 5'-GTGGTTGTAAGGCGGTTTGT-3' associated to 5'-ACGCGAGCTCCAGAAAAAGT-3' for the wild-type allele. Primer pairs for Nanog genotyping (Mitsui et al., 2003) , using the Taq polymerase (Invitrogen or Promega) were: 5'-CAGAATGCAGACAGGTCTACAGCCCG-3' coupled with either 5'-AATGGGCTGACCGCTTCCTCGTGCTT-3' for the mutated allele or 5'-GGCCCAGCTGTGTGCACTCAA-3' for the wild-type allele.
Embryo cultures and immunostaining
Embryos were flushed with M2 (Sigma Aldrich) and cultured in KSOM medium (Millipore) for the indicated time points. Embryos were treated with FGFR inhibitor (PD173074, Sigma Aldrich) at 100nM and MEK1 inhibitor (PD0325901, Sigma Aldrich) at 500nM (Frankenberg et al., 2011) . Blastocysts immunostainings were performed as previously described ) (see antibodies list, Supp data Table 1) Images were captured with confocal microscopes Leica SPE, SP5 and Sp8 using 40X objectives. Images were analysed with ImageJ (NIH) and Imaris (Bitplane) softwares. Cell counts were performed as previously described (Bessonnard et al., 2014) . ICM cell numbers were counted by subtracting the number of CDX2 expressing cells to the total (dapi-labelled) cell number. Unless indicated, images show single confocal image z-slices.
RT-qPCR on single ICM
RT-qPCR on single ICM was adapted from described protocols (Ralston et al., 2010; Tang et al., 2010) .
Boxplots presentation
The edges of the box represent 25th and 75th quartiles. The median is represented by the central line. The whiskers extend to 1.5 times the interquartile range (25th to 75th percentile)
Cells are plotted individually in single-cell experiments.
Single cell isolation and RT-qPCR/Fluidigm analysis Isolated ICM cells (after immunosurgery) and morulae (16C) were incubated 10 minutes in 1X TrypLE™ Express Enzyme (Gibco) at 37°C and cells were isolated by repeated mouth pipetting using pulled capillaries of serially smaller diameter openings. Each single cell was collected in 5µl of 2X Reaction Mix (Invitrogen, CellsDirect One-Step qRT-PCR Kit) and stored at -80°C or processed immediately.
Single-cell qPCR on a Fluidigm Biomark system (GENTYANE facility) was carried out according to the manufacturer's instructions. Cells with absent or low Ct values for housekeeping genes were removed from analysis (5%). Ct values were normalized using the 2-ΔCt method. In boxplots, values are relative to the mean of all WT 32C cells (WT-ref and
WT from the transgenic background when available) to be able to compare between genotypes and stages. Cells were considered in Fgf4-ve subpopulations when CT values were above 35 and all other cells were placed in Fgf4+ve subpopulations.
Statistical analyses.
Statistical tests were performed with Graphpad software or R. Statistical significance was assessed using the Wilcoxon-Mann-Whitney test (non parametric) on expression levels (see the different Excel sheets in SI 8). A Fligner-Killeen non-parametric test for homogeneity of variance was performed to analyse the distribution of Fgf4+ve cells between WT and DKO cells.
Generation of heatmaps
To construct heatmaps, we used R with the package « pheatmap » (Kolde R. 2015. Package 'pheatmap': https://CRAN.R-project.org/package=pheatmap). We made a log base 2 transformation on cells expression values. Then we applied a hierarchical clustering algorithm on both cells and genes values to obtain the final heatmap with dendogram showing distances.
PCA analyses
Principal component analyses were performed using R package « pcaMethods » using « bpca» method (Stacklies et al., 2007) to compute component scores on log2 expression values from stages and genotypes. Scatter plots showing the distribution of cells and of genes between the two main components (PC1 and PC2) were produced.
To analyse the clustering between Fgf4+ve and Fgf4-ve cells, we first used a repeated kmeans clustering method with k=2 on each sample (32C, 64C and 90C WT-Ref, WT and DKO) . We then analysed the distribution of Fgf4+ve and Fgf4-ve cells within the clusters using a Fisher's exact test to examine the significance of the association between the two kinds of classification.
Single-cell RNA-seq expression correlation analyses
Single-cell expression data were extracted from (Posfai et al., 2017) , taking 40 ICM cells from the 32C stage (early and late) and 33 inner cells from the 16C stage (already defined by Posfai and collaborators) (Posfai et al., 2017) .
All correlation rho scores and p values were performed using R package "HMisc" with the Spearman method. To obtain correlation heatmap for 32C stage, we first computed all expression correlations between Fgf4 and all the genes at 32C stage. Genes that had rho score >= 0,3 (corresponding to p <= 0,05 for 40 samples) were kept for building the matrix.
Correlation scores in between these genes were computed and discretized in 3 individuals' values: 1= correlated (rho score >= 0,3), -1 = anticorrelated (rho score <=-0,3), 0 = no correlation (otherwise).
To obtain correlation matrix for 16 cells stage we used the 1434 genes selected as correlated or anticorrelated to Fgf4 expression at 32C stage. All correlation scores between these genes were computed and correlation was considered significant when rho score>= 0,345 (corresponding to p <= 0,05 for 33 samples). Then we discretized these values in 3
individuals' values: 1= correlated (rho score >= 0,345), -1 = anticorrelated (rscore <=-0,345), 0 = no correlation (otherwise).
Heatmaps were generated using R package "pheatmap".
Comparison Gene plot
Comparison gene plots were made using R package "ggplot2" using "geompoint()" function. Supp data Figure 2 : a, Heatmap indicating the relative expression levels of 44 genes in WT single ICM cells at the four stages, and ordered through an unsupervised hierarchical clustering. b, PCA loading map (see Fig 2c) showing the distribution of the measured gene expression levels. Epi and PrE genes are labelled in blue and green respectively. c, PCA map shown in (Fig. 2c ) with graded colours indicating the level of different genes expression in each cell at the four stages. For Etv5 and Klf4, experiments on 16C stage cells were not carried out. Supp data Figure 5 : PCA map of Fig. 2g showing only the 16C stage with different genes expression gradient (as in Supp data Fig. 2c ). Fgf4 is not detected at this stage (see Supp data Fig.2c ). . ETV5 cannot be detected before stage 32C, there is a weak expression in few ICM cells in few embryos at stage 32C (not shown) and from the 64C stage expression can be seen in some ICM cells, mainly colocalized with NANOG. scale bar: 10 µm.
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